PERP B — Perpetua Medical AB (publ) Income Statement
0.000.00%
- SEK16.77m
- SEK5.66m
- SEK9.94m
- 27
- 21
- 45
- 20
Annual income statement for Perpetua Medical AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | SAS | SAS | SAS | SAS | SAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2.18 | 1.9 | 8.82 | 10.1 | 9.94 |
Cost of Revenue | |||||
Gross Profit | 1.54 | 0.944 | 5.93 | 6.65 | 5.85 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 17.7 | 16.4 | 22.5 | 29.2 | 28.4 |
Operating Profit | -15.5 | -14.5 | -13.7 | -19.1 | -18.5 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -16.7 | -14.6 | -13.7 | -19.2 | -18.3 |
Net Income After Taxes | -16.7 | -14.6 | -13.7 | -19.2 | -18.3 |
Net Income Before Extraordinary Items | |||||
Net Income | -16.7 | -14.6 | -13.7 | -19.2 | -18.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -16.7 | -14.6 | -13.7 | -19.2 | -18.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.55 | -0.914 | -0.711 | -0.931 | -0.44 |
Dividends per Share |